White Paper

CAR-T: Advancing the Path for Clinical and Commercial Success

Posted on 09/25/2018

By: Ben Doran, Stuart Crichton, Ben Druck and Vasiliki Patsioura

The Prescient team has prepared a white paper discussing our view on the recent advances in the CAR-T landscape. In this paper, we do not focus on the already well-documented challenges, but rather present our view on the recent advances in the relatively short period of time since the first regulatory approvals. Industry and academia appear to be making significant strides in simplifying manufacturing and administration processes, expanding clinical utility and enabling access for patients. These advances can be summarized as follows:

 

Request our White Paper via Email

Back to Insights & Experience